Professor | Wei Tuo | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Wei Tuo
Contact Information	weituo@ioz.ac.cn
Language ability	English, Chinese, French
Province	Beijing

Upload Avatar (500 x 500)

Name

Wei Tuo

Contact Information

weituo@ioz.ac.cn

Language ability

English, Chinese, French

Province

Beijing

University/Lab Affiliation and Title	Chinese Academy of Sciences
Faculty	Institute of Zoology
Academic Background & Achievements	PhD: University of Chinese Academy of Sciences/National Center for Nanoscience and Technology and Aix-Marseille University Published over 40 academic papers in international journals Cited over 5800 times, H-index of 31 Applied for 13 domestic and international patents (9 granted)
Work Experience	2015-2021 - Harvard Medical School, Boston Children's Hospital, MIT, University of Texas Southwestern Medical Center - Postdoctoral Research 2021-Present - Institute of Zoology, Chinese Academy of Sciences - Researcher

University/Lab Affiliation and Title

Chinese Academy of Sciences

Faculty

Institute of Zoology

Academic Background & Achievements

PhD: University of Chinese Academy of Sciences/National Center for Nanoscience and Technology and Aix-Marseille University
Published over 40 academic papers in international journals
Cited over 5800 times, H-index of 31
Applied for 13 domestic and international patents (9 granted)

Work Experience

2015-2021 - Harvard Medical School, Boston Children's Hospital, MIT, University of Texas Southwestern Medical Center - Postdoctoral Research
2021-Present - Institute of Zoology, Chinese Academy of Sciences - Researcher

Areas of Focus	Development of organ or cell-targeted lipid nanoparticle delivery systems Development of novel gene editing delivery systems and gene editing therapy Targeted gene therapy research for major diseases (e.g., tumors, metabolic diseases, genetic diseases)
Publications	Surface Engineering of Lipid Nanoparticles: Targeted Nucleic Acid Delivery and Beyond, Lin Y, Cheng Q, Wei T, 2023 Lung SORT LNPs enable precise homology-directed repair mediated CRISPR/Cas genome correction in cystic fibrosis models, Wei T#, Sun Y#, Cheng Q#, Chatterjee S, Traylor Z, Johnson LT, Coquelin ML, Wang J, Torres MJ, Lian X, Wang X, Xiao Y, Hodges CA, Siegwart DJ, 2023 Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer Therapy, Zong Y, Lin Y, Wei T, Cheng Q, 2023 Lipid nanoparticles for mRNA therapy: recent advances in targeted delivery, Wei T, Tao W, Cheng Q, 2022 Systemic nanoparticle delivery of CRISPR/Cas9 ribonucleoproteins for effective tissue-specific genome editing, Wei T#, Cheng Q#, Min YL, Olson EN, Siegwart DJ, 2020 Selective ORgan Targeting (SORT) nanoparticles for tissue specific mRNA delivery and CRISPR/Cas gene editing, Cheng Q#, Wei T#, Farbiak L, Johnson LT, Dilliard SA, Siegwart DJ, 2020 Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for in Vivo CRISPR/Cas-Based Genome Editing, Wei T, Cheng Q, Farbiak L, Anderson DG, Langer R, Siegwart DJ, 2020 Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance, Liu J#, Wei T#, Zhao J, Huang Y, Deng H, Kumar A, Wang C, Liang Z, Ma X, Liang X-J, 2016 Anticancer drug nanomicelles formed by self-assembling amphiphilic dendrimer to combat cancer drug resistance, Wei T, Chen C, Liu J, Liu C, Posocco P, Liu X, Cheng Q, Huo S, Liang Z, Fermeglia M, Pricl S, Liang X-J, Rocchi P, Peng L, 2015 Functionalized Nanoscale Micelles Improve Drug Delivery for Cancer Therapy in Vitro and in Vivo, Wei T#, Liu J#, Ma H, Cheng Q, Huang Y, Zhao J, Huo S, Xue X, Liang Z, Liang X-J*, 2013

Areas of Focus

Development of organ or cell-targeted lipid nanoparticle delivery systems
Development of novel gene editing delivery systems and gene editing therapy
Targeted gene therapy research for major diseases (e.g., tumors, metabolic diseases, genetic diseases)

Publications

Surface Engineering of Lipid Nanoparticles: Targeted Nucleic Acid Delivery and Beyond, Lin Y, Cheng Q*, Wei T*, 2023
Lung SORT LNPs enable precise homology-directed repair mediated CRISPR/Cas genome correction in cystic fibrosis models, Wei T#, Sun Y#, Cheng Q#, Chatterjee S, Traylor Z, Johnson LT, Coquelin ML, Wang J, Torres MJ, Lian X, Wang X, Xiao Y, Hodges CA, Siegwart DJ, 2023
Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer Therapy, Zong Y, Lin Y, Wei T*, Cheng Q*, 2023
Lipid nanoparticles for mRNA therapy: recent advances in targeted delivery, Wei T*, Tao W*, Cheng Q*, 2022
Systemic nanoparticle delivery of CRISPR/Cas9 ribonucleoproteins for effective tissue-specific genome editing, Wei T#, Cheng Q#, Min YL, Olson EN, Siegwart DJ*, 2020
Selective ORgan Targeting (SORT) nanoparticles for tissue specific mRNA delivery and CRISPR/Cas gene editing, Cheng Q#, Wei T#, Farbiak L, Johnson LT, Dilliard SA, Siegwart DJ*, 2020
Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for in Vivo CRISPR/Cas-Based Genome Editing, Wei T, Cheng Q, Farbiak L, Anderson DG*, Langer R*, Siegwart DJ*, 2020
Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance, Liu J#, Wei T#, Zhao J, Huang Y, Deng H, Kumar A, Wang C, Liang Z, Ma X*, Liang X-J*, 2016
Anticancer drug nanomicelles formed by self-assembling amphiphilic dendrimer to combat cancer drug resistance, Wei T, Chen C, Liu J, Liu C, Posocco P, Liu X, Cheng Q, Huo S, Liang Z, Fermeglia M, Pricl S, Liang X-J*, Rocchi P, Peng L*, 2015
Functionalized Nanoscale Micelles Improve Drug Delivery for Cancer Therapy in Vitro and in Vivo, Wei T#, Liu J#, Ma H, Cheng Q, Huang Y, Zhao J, Huo S, Xue X, Liang Z, Liang X-J*, 2013

Nanoparticles Lipid Gene Therapy Crispr Cancer Genetic Diseases Drug Delivery Biomedicine Targeted Therapy Nanotechnology

Hu Zheng - Chinese Academy of Sciences

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us